IHuman Inc. Reports Q2 GAAP EPS of $0.07, Revenue of $34.4M

Trending News 🌥️

Ihuman Inc Intrinsic Value – IHUMAN($NYSE:IH): The company attributed this growth to their expanding product portfolio and continued investment in research and development.

Earnings

In their latest earning report of FY2022 Q1, IHUMAN INC earned 960.7M CNY in total revenue, lost 31.1M CNY in net income. Compared to the previous year, there was a 1.7% increase in total revenue. IHUMAN INC’s total revenue reached from 531.9M CNY to 960.7M CNY in the last 3 years.

Stock Price

On Thursday, shares of iHuman Inc. opened at $2.00 and closed at $1.80, down 9.0% from the previous close of $2.00. In addition to the weak financial results, iHuman also announced that its CEO and CFO would be stepping down from their roles. This news added to the selling pressure on the stock and caused it to close below its opening price for the day.

VI Analysis – Ihuman Inc Intrinsic Value Calculator

IHUMAN INC’s fundamentals reflect its long term potential, as seen by the company’s strong financials and positive outlook. The VI Line app calculates the fair value of IHUMAN INC shares to be around $11.7, meaning that the stock is currently undervalued by 85%. This presents a great opportunity for investors looking to buy into a company with strong long-term prospects.

Summary

IHuman Inc. reported their second quarter earnings today and beat expectations on both their EPS and revenue. There are a few potential reasons for this.

First, IHuman’s guidance for the rest of the year was lower than what analysts were expecting. Second, IHuman’s revenue growth has been slowing down in recent quarters. While 34.4% growth is still impressive, it’s a far cry from the triple digit growth the company was posting a few years ago. Finally, IHuman is still a relatively new company and is yet to turn a profit. For now, it seems investors are content to wait for the company to mature a bit more before putting their money in.